Research
Print page Print page
Switch language
  1. The Capital Region of Denmark
  2. Publications
  3. Very low carbohydrate diet and...
  4. Citationformats
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Very low carbohydrate diet and SGLT-2-inhibitor: double jeopardy in relation to ketoacidosis

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Tougaard, NH, Faber, J & Eldrup, E 2019, 'Very low carbohydrate diet and SGLT-2-inhibitor: double jeopardy in relation to ketoacidosis' BMJ Case Reports , vol. 12, no. 4. https://doi.org/10.1136/bcr-2018-227516

APA

Tougaard, N. H., Faber, J., & Eldrup, E. (2019). Very low carbohydrate diet and SGLT-2-inhibitor: double jeopardy in relation to ketoacidosis. BMJ Case Reports , 12(4). https://doi.org/10.1136/bcr-2018-227516

CBE

Tougaard NH, Faber J, Eldrup E. 2019. Very low carbohydrate diet and SGLT-2-inhibitor: double jeopardy in relation to ketoacidosis. BMJ Case Reports . 12(4). https://doi.org/10.1136/bcr-2018-227516

MLA

Tougaard, Ninna Hahn, Jens Faber, and Ebbe Eldrup. "Very low carbohydrate diet and SGLT-2-inhibitor: double jeopardy in relation to ketoacidosis". BMJ Case Reports . 2019. 12(4). https://doi.org/10.1136/bcr-2018-227516

Vancouver

Tougaard NH, Faber J, Eldrup E. Very low carbohydrate diet and SGLT-2-inhibitor: double jeopardy in relation to ketoacidosis. BMJ Case Reports . 2019 Apr 5;12(4). https://doi.org/10.1136/bcr-2018-227516

Author

Tougaard, Ninna Hahn ; Faber, Jens ; Eldrup, Ebbe. / Very low carbohydrate diet and SGLT-2-inhibitor : double jeopardy in relation to ketoacidosis. In: BMJ Case Reports . 2019 ; Vol. 12, No. 4.

Bibtex

@article{d921b157b68b4f1f970abaaa02c1b6c7,
title = "Very low carbohydrate diet and SGLT-2-inhibitor: double jeopardy in relation to ketoacidosis",
abstract = "Diabetic euglycaemic ketoacidosis is a possible adverse effect of sodium-glucose co-transporter-2 inhibitors (SGLT2i). We report a case in which the combination of SGLT2i and a strict very low-carbohydrate diet led to severe diabetic ketoacidosis in a young Caucasian man with type 2 diabetes.",
keywords = "Adult, Blood Glucose/drug effects, Diabetes Mellitus, Type 2/metabolism, Diabetic Ketoacidosis/diagnosis, Diet, Carbohydrate-Restricted/adverse effects, Diet, Reducing/adverse effects, Directive Counseling, Humans, Hypoglycemic Agents/therapeutic use, Male, Obesity/physiopathology, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Treatment Outcome",
author = "Tougaard, {Ninna Hahn} and Jens Faber and Ebbe Eldrup",
note = "{\circledC} BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.",
year = "2019",
month = "4",
day = "5",
doi = "10.1136/bcr-2018-227516",
language = "English",
volume = "12",
journal = "JMM Case Reports",
issn = "1757-790X",
publisher = "B M J Group",
number = "4",

}

RIS

TY - JOUR

T1 - Very low carbohydrate diet and SGLT-2-inhibitor

T2 - double jeopardy in relation to ketoacidosis

AU - Tougaard, Ninna Hahn

AU - Faber, Jens

AU - Eldrup, Ebbe

N1 - © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

PY - 2019/4/5

Y1 - 2019/4/5

N2 - Diabetic euglycaemic ketoacidosis is a possible adverse effect of sodium-glucose co-transporter-2 inhibitors (SGLT2i). We report a case in which the combination of SGLT2i and a strict very low-carbohydrate diet led to severe diabetic ketoacidosis in a young Caucasian man with type 2 diabetes.

AB - Diabetic euglycaemic ketoacidosis is a possible adverse effect of sodium-glucose co-transporter-2 inhibitors (SGLT2i). We report a case in which the combination of SGLT2i and a strict very low-carbohydrate diet led to severe diabetic ketoacidosis in a young Caucasian man with type 2 diabetes.

KW - Adult

KW - Blood Glucose/drug effects

KW - Diabetes Mellitus, Type 2/metabolism

KW - Diabetic Ketoacidosis/diagnosis

KW - Diet, Carbohydrate-Restricted/adverse effects

KW - Diet, Reducing/adverse effects

KW - Directive Counseling

KW - Humans

KW - Hypoglycemic Agents/therapeutic use

KW - Male

KW - Obesity/physiopathology

KW - Sodium-Glucose Transporter 2 Inhibitors/adverse effects

KW - Treatment Outcome

U2 - 10.1136/bcr-2018-227516

DO - 10.1136/bcr-2018-227516

M3 - Journal article

VL - 12

JO - JMM Case Reports

JF - JMM Case Reports

SN - 1757-790X

IS - 4

ER -

ID: 59085909